Cell Therapy Manufacturing Market - Global Industry Insights,
Trends, Outlook and Opportunity Analysis, 2018-2026
Cell therapy is one of the most promising healthcare procedure for restoration of damaged tissue.
Cell therapies have huge potential for the wide range of disease treatment including tissue
degradation, immune deficiency, metabolic disorders, and cancer. Cell therapy are categorized into
two type’s allogeneic (cells from third party donor) and autologous (cells from one’s own body).
Cell therapy has gained significant traction in recent past and currently it under commercial
development. Main objective of cell therapy is to re-establish the lost function of tissues and cells
rather than to produce a new organ. Some cell therapies have been established and permitted for
clinical trial. For instance, in 2013 a stage 2 clinical trial was completed for transplantation of bone
marrow derived stem cells in affected knee by rheumatoid arthritis. The growth of this technique is
also increased due to involvement of the government agencies. For instance, innovate U.K. 2014
report showed that government agreed to fund US$15.3 million in cell therapy manufacturing
market.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1728
Cell Therapy Manufacturing Market Dynamics
Increasing number of surgical procedures performed across the world coupled with increasing
number of trauma and accidents is propelling demand for new medical therapy. For instance,
according to a 2015, World Health Organization (WHO) report, more than 50,000 stem cell
transplants are carried out annually worldwide for various surgeries. Stem cells transplantation is
promising medical therapy for patients with advance stage diseases like Alzheimer’s, arthritis,